Gene · 6118
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RAD54L2-mediated DNA damage avoidance pathway specifically preserves genome integrity in response to topoisomerase 2 poisons. | Sci Adv | 2023 | 38055811 | PubTator, text mining | PubMed |
| FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe. | Cancer Res Commun | 2023 | 38032106 | PubTator, text mining | PubMed |
| Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targeting. | Nat Commun | 2023 | 38030626 | PubTator, text mining | PubMed |
| Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair. | Cell Biosci | 2023 | 38007480 | PubTator, text mining | PubMed |
| Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1-KMT2A Interaction. | Int J Mol Sci | 2023 | 38003662 | PubTator, text mining | PubMed |
| Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilities. | Nat Commun | 2023 | 38001070 | PubTator, text mining | PubMed |
| CDK5: an oncogene or an anti-oncogene: location location location. | Mol Cancer | 2023 | 37993880 | PubTator, text mining | PubMed |
| STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition. | Adv Sci (Weinh) | 2023 | 37985839 | PubTator, text mining | PubMed |
| Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51. | Nat Commun | 2023 | 37973845 | PubTator, text mining | PubMed |
| The nucleolar protein GNL3 prevents resection of stalled replication forks. | EMBO Rep | 2023 | 37965896 | PubTator, text mining | PubMed |
| TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. | Nucleic Acids Res | 2023 | 37953292 | PubTator, text mining | PubMed |
| HELQ as a DNA helicase: Its novel role in normal cell function and tumorigenesis (Review). | Oncol Rep | 2023 | 37921071 | PubTator, text mining | PubMed |
| Interplay between the DNA damage response and the life cycle of DNA tumor viruses. | Tumour Virus Res | 2023 | 37918513 | PubTator, text mining | PubMed |
| Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma. | bioRxiv | 2023 | 37905107 | PubTator, text mining | PubMed |
| Human HELQ regulates DNA end resection at DNA double-strand breaks and stalled replication forks. | Nucleic Acids Res | 2023 | 37897354 | PubTator, text mining | PubMed |
| Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy. | Int J Mol Sci | 2023 | 37895091 | PubTator, text mining | PubMed |
| FIGNL1 AAA+ ATPase remodels RAD51 and DMC1 filaments in pre-meiotic DNA replication and meiotic recombination. | Nat Commun | 2023 | 37891173 | PubTator, text mining | PubMed |
| Atypical genotoxicity of carcinogenic nickel(II): Linkage to dNTP biosynthesis, DNA-incorporated rNMPs, and impaired repair of TOP1-DNA crosslinks. | J Biol Chem | 2023 | 37890780 | PubTator, text mining | PubMed |
| Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma. | Res Sq | 2023 | 37886584 | PubTator, text mining | PubMed |
| GSE1 links the HDAC1/CoREST co-repressor complex to DNA damage. | Nucleic Acids Res | 2023 | 37878419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6118/papers?page=7